Australia's largest stock trading and investment forum Australia's #1 stock forum

APT

0.00%

$66.47 afterpay limited

The business model is suspect and the inherent risks in it - let...

First 375 Last

Share
Profile

Follow
doubledeckerdog

4,955 Posts.

1100

09/03/20

14:59

Post #: 43384187
Share

Originally posted by casajack: ↑

Here is the real question - is this week/month a time to sell or a time to buy - over a + 6 month horizon.

The number of trolls declaring APT's demise always increases after the big pullbacks happen (happy with themselves & their opinion & like to see that published or if they've shorted, sitting on profits & I congratulate), just as the bulls get excited after the big rises (they're sitting on profits & happy with themselves). Most don't call it prior to the big movements … except PB.

Considering the moves to cash at the moment (bonds earning nothing & sharemarket selling to cash at back earning nothing) - only two things can happen once some semblance of confidence returns - deflation or massive flow of money back into equities (where there is a prospect of a real return).

The world is not ending, though I am certainly on edge considering my losses piling up across my portfolio over the past two weeks.

BTW this current selloff in APT is not a question of business model, access to funds that you are cheerleading for, it is simply a move away from risk.

Expand

The business model is suspect and the inherent risks in it - let alone the lack of profitability - will see the stock trade a lot lower yet.
Back up your truck, take some of the cheap stock from the many punters wanting to get the heck out.
Consider it an act of philanthropy.
DDD

APT Price at posting: $28.06 Sentiment: Sell Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 574 more messages in this thread...

First 375 Last

Add APT (ASX) to my watchlist

The business model is suspect and the inherent risks in it - let...

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News